Biology subjects

Oh, U.

Publications and source records attributed to Oh, U..

4 recordsLinked to original sources

bioRxiv2026

Astrocyte-oligodendrocyte crosstalk dependent myelination via secreted protein YKL40

Although oligodendrocyte differentiation and myelin formation are inherent properties of oligodendrocyte progenitor cells (OPCs) that are guided by intrinsic transcriptional and epigenetic programs, this process in the brain is finely regulated by signals coming from other cells, including astrocytes. Here, we identified the astrocyte secreted protein YKL40 at the center of astrocyte-OPC cross-communication and myelination in the developing brain. We find that YKL40 is expressed by astrocytes within white matter areas in the developing brain, coinciding with the OPC differentiation and myelination. Deletion of YKL40 in astrocytes showed delayed developmental myelination and reduced OPC proliferation. Interestingly, coculture with OPCs in vitro specifically induces YKL40 expression in astrocytes, which in turn promotes OPC differentiation and OPC proliferation. Mechanistically, purified YKL40 significantly induced the expression of transcription factors Olig2 and MYRF (Myeline regulatory factor) in OPCs. Therefore, we identified a novel mechanism of OPC-astrocyte crosscommunication dependent myelination by astrocytic YKL40 in the developing brain.

neuroscience↗

bioRxiv2026

Potential Role of Nociceptin/Orphanin FQ in the Progression of Multiple Sclerosis

We showed before that the endogenous peptide Nociceptin blocks the premature differentiation of oligodendrocytes (OLGs), preventing untimely precocious myelination in the developing brain. Consistent with this early function, Nociceptin brain expression is developmentally regulated, sharply decreasing with the initiation and progression of myelination. However, we now found that at difference with controls and relapsing-remitting multiple sclerosis (RRMS), Nociceptin levels are highly elevated in cerebrospinal fluid from patients with the most severe progressive MS (PMS) forms. This questioned whether Nociceptin early developmental effects could be latter recapitulated, interfering with remyelination in PMS. This possibility was tested by inducing experimental autoimmune encephalomyelitis in older mice, at an age equivalent to that with increased risk of RRMS transition into PMS. Older animals develop persistently highly debilitating clinical symptoms, and display both brain and spinal cord demyelination. Importantly, these mice exhibit elevated brain Nociceptin levels, and their treatment with an antagonist of the Nociceptin receptor (NOR) elicits a regression of clinical scoring that is accompanied by higher ratios of OLGs/OLG progenitor cells, increased myelination, and reduction of reactive astrocytes. These findings suggest that Nociceptin may be a crucial player in the age-related progression of MS; interfering with OLG maturation and remyelination, and perhaps further exacerbating neurological dysfunction by targeting astrocyte populations. The upregulation of Nociceptin secretion by human astrocytes in response to proinflammatory cytokines, also points to this peptide as a mediator of microglia-astrocyte interactions supporting MS progression with aging. NOR may offer a novel pharmacological target for ameliorating the devastating effects of MS progression.

neuroscience↗

bioRxiv2022

Amplification of Olfactory Signals by Anoctamin 9 is Essential for Mammalian Olfaction: a Risk Factor for the Covid-19-associated Anosmia

Sensing smells of foods, prey, or predators determines animal survival. Olfactory sensory neurons in the olfactory epithelium (OE) detect odorants, where cAMP and Ca2+ play a significant role in transducing odorant inputs to electrical activity. Here we show Anoctamin 9, a cation channel activated by cAMP/PKA pathway, is expressed in the OE and amplifies olfactory signals. Ano9- deficient mice had reduced olfactory behavioral sensitivity, electro-olfactogram signals, and neural activity in the olfactory bulb. In line with the difference in olfaction between birds and other vertebrates, chick ANO9 failed to respond to odorants, whereas chick CNGA2, a major transduction channel, showed greater responses to cAMP. Importantly, single-cell transcriptome data from Covid-19 patients revealed that Ano9 transcripts were markedly suppressed among genes in the olfactory signal pathway. The signal amplification by ANO9 is essential for mammalian olfactory transduction, whose downregulation may be a risk factor for the olfactory dysfunction in Covid-19 patients.

cell biology↗

bioRxiv2017

Anoctamin 9/TMEM16J is a Cation Channel Activated by cAMP/PKA Signal

Anoctamins are membrane proteins that consist of 10 homologs. ANO1 and ANO2 are anion channels activated by intracellular calcium that meditate numerous physiological functions. ANO6 is a scramblase that redistributes phospholipids across the cell membrane. However, the others are not well characterized. We found ANO9/TMEM16J is a cation channel activated by a cAMP-dependent PKA. Intracellular cAMP activated robust currents in whole-cells expressing ANO9 and inhibited by PKA blockers. A cholera toxin and purified PKA also activated ANO9. The cAMP-induced ANO9 currents were permeable to cations. The mutation of a possible phosphorylation site at Ser245 elicited a block of the cAMP-dependent activation. High levels of Ano9 transcripts were found in intestines. Human intestinal SW480 cells showed cAMP-dependent currents. We conclude that ANO9 is a cation channel activated by the cAMP/PKA pathway and could play a role in intestine function.

biophysics↗